Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Deborah Collyar: What's In It for Patients?

Varsha Gandhi, PhD, on Ibrutinib

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Jan
29
Today In Oncology
Tislelizumab Plus Chemotherapy Improves Progression-Free Survival in Nasopharyngeal Cancer
Treatment De-escalation in HPV-Associated Oropharyngeal Cancer Using Primary Radiotherapy vs Transoral Surgery
Gabapentin May Be an Effective Alternative to Opioids for Patients With Head and Neck Cancer Receiving Radiation
Role of Combined Positive Score With Treatment Outcomes in Recurrent or Metastatic Head and Neck Cancer
Study Finds Black and Hispanic Men With Throat Cancer Are Experiencing Higher Mortality White Men Are Increasingly Being Diagnosed at a Late Stage
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo